Drug General Information
Drug ID
D0AF3A
Former ID
DNC001154
Drug Name
Protoporphyrin IX
Drug Type
Small molecular drug
Indication Discovery agent Investigative [536585]
Structure
Download
2D MOL

3D MOL

Formula
C34H34N4O4
Canonical SMILES
CC1=C(C2=CC3=C(C(=C(N3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=<br />C1N2)C)CCC(=O)O)CCC(=O)O)C)C=C)C)C=C
InChI
1S/C34H34N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,13-16,35-36H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42)
InChIKey
ZCFFYALKHPIRKJ-UHFFFAOYSA-N
CAS Number
CAS 15415-30-2
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:15430
SuperDrug ATC ID
B06AB01
SuperDrug CAS ID
cas=015489904
Target and Pathway
Target(s) Glutathione S-transferase Target Info Inhibitor [536585]
BioCyc Pathway C20 prostanoid biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
WikiPathways Arachidonic acid metabolism
Aryl Hydrocarbon Receptor
Integrated Pancreatic Cancer Pathway
References
Ref 536585Inhibition of glutathione-S-transferase from Plasmodium yoelii by protoporphyrin IX, cibacron blue and menadione: implications and therapeutic benefits. Parasitol Res. 2008 Mar;102(4):805-7. Epub 2008 Jan 5.
Ref 536585Inhibition of glutathione-S-transferase from Plasmodium yoelii by protoporphyrin IX, cibacron blue and menadione: implications and therapeutic benefits. Parasitol Res. 2008 Mar;102(4):805-7. Epub 2008 Jan 5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.